Revvity Inc. RVTY
151.11
0.43
0.29%
as of 25 Sep
- Market cap
- $16.8B
- P/E
- 72.0×
Follow RVTY
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Revvity Inc. (RVTY) Net income
Revvity Inc.'s net income for fiscal 2025 was $241.2M, down 10.8% from $270.4M in fiscal 2024. Over the twelve months to 30 June 2026 it was $237.6M. Over the past ten years it has ranged from $212.4M (fiscal 2015) to $943.2M (fiscal 2021); the current reading is higher than 45% of that period. Revvity Inc. ranks 12th of 52 Diagnostics & Research companies by net income.
Net income, annual
Annual
| Period | Net income | Change |
|---|---|---|
| FY2025 | $241.2M | (10.79%) |
| FY2024 | $270.4M | (60.99%) |
| FY2023 | $693.1M | 21.77% |
| FY2022 | $569.2M | (39.65%) |
| FY2021 | $943.2M | 29.57% |
| FY2020 | $727.9M | 219.87% |
| FY2019 | $227.6M | (4.36%) |
| FY2018 | $237.9M | (18.69%) |
| FY2017 | $292.6M | 24.90% |
| FY2016 | $234.3M | 10.30% |
Quarterly
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $51.8M | 27.27% |
| Mar 2026 | $40.7M | (58.60%) |
| Dec 2025 | $98.4M | 110.85% |
| Sep 2025 | $46.7M | (13.52%) |
| 42 more quarters | Free account |
Against its own ten years
Low $212.4M
High $943.2M
Ten-year median
$270.4M
Current reading's percentile
45
Net income against peers
| Company | Net income |
|---|---|
| DGX Quest Diagnostics Incorporated compare | $1.1B |
| LH Labcorp Holdings Inc. compare | $1.0B |
| MTD Mettler-Toledo International, Inc. compare | $905.6M |
| MEDP Medpace Holdings, Inc. compare | $491.5M |
| RVTY Revvity Inc. | $237.6M |
| ICLR ICON PLC compare | $42.3M |
| TWST Twist Bioscience Corporation compare | −$136.7M |
| CRL Charles River Laboratories International, Inc. compare | −$236.3M |
| GH Guardant Health, Inc. compare | −$453.4M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on RVTY
- Revenue
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement